U.S. patents available from 1976 to present.
U.S. patent applications available from 2005 to present.

Icon_funbox Today In History

Robert Mushet received a patent for methods of manufacturing steel.

Newsletter  PatentStorm News

Make the Most of Our Site

See this month's Top Inventors and Most Cited Patents.

Stay on top of the latest innovations by subscribing to an RSS feed.

Registered users: Manage your profile.

 

Assignee: Sirtris Pharmaceuticals, Inc.


Location: Cambridge, MA,
No. of applications: 12

Application No.Application TitleIssue Date
20080293081Fluorescence Polarization Assays for Acetyltransferase/Deacetylase Activity
Provided are methods for determining the activity of proteins that modulate the acetylation state of a protein substrate. The methods may be used for determining both acetyltransferase activity and deacetylase activity. The methods involve fluorescence polarization meas...
11/27/2008
20080249130Gut microsomal triglyceride transport protein inhibitors
Compounds represented by formula (I):

are inhibitors of gut microsomal triglyceride transfer protein. Such compounds are useful in treating diseases or conditions such as diabetes and obesity, along with pati...

10/09/2008
20080249103Sirtuin polymorphisms and methods of use thereof
Provided herein are methods for diagnosis and prognosis using polymorphic variants of sirtuins. Such polymorphic may be used, for example, to identify subjects that would be responsive to treatment with a sirtuin modulating compound and/or subjects that are suffering fr...
10/09/2008
20070248590Modulators of CDC2-like kinases (CLKS) and methods of use thereof
Provided herein are methods for using Cdc2-like kinase (Clk) modulators for treating and/or preventing a wide variety of diseases and disorders including, for example, diseases or disorders related to aging or stress, diabetes, obesity, neurodegenerative diseases, cardi...
10/25/2007
20070043050Sirtuin modulating compounds
Provided herein are novel sirtuin-modulating compounds and methods of use thereof. The sirtuin-modulating compounds may be used for increasing the lifespan of a cell, and treating and/or preventing a wide variety of diseases and disorders including, for example, disease...
02/22/2007
20070037865Sirtuin modulating compounds
Provided herein are novel sirtuin-modulating compounds and methods of use thereof. The sirtuin-modulating compounds may be used for increasing the lifespan of a cell, and treating and/or preventing a wide variety of diseases and disorders including, for example, disease...
02/15/2007
20070037827Sirtuin modulating compounds
Provided herein are novel sirtuin-modulating compounds and methods of use thereof. The sirtuin-modulating compounds may be used for increasing the lifespan of a cell, and treating and/or preventing a wide variety of diseases and disorders including, for example, disease...
02/15/2007
20070037809Sirtuin modulating compounds
Provided herein are novel sirtuin-modulating compounds and methods of use thereof. The sirtuin-modulating compounds may be used for increasing the lifespan of a cell, and treating and/or preventing a wide variety of diseases and disorders including, for example, disease...
02/15/2007
20070014833Treatment of eye disorders with sirtuin modulators
Sirtuin modulators, particularly sirtuin activators, are useful in treating vision impairment. In general, the sirtuin modulators inhibit the progression of vision impairment resulting from various eye disorders. The invention also includes pharmaceutically acceptable f...
01/18/2007
20060276416Methods and compositions for treating flushing and drug induced weight gain
Provided herein are methods and compositions for treating and/or preventing flushing and/or weight gain. Methods may comprise modulating the activity or level of a sirtuin, such as SIRT1 or Sir2. Exemplary embodiments include methods and compositions for counteracting d...
12/07/2006
20060276393Novel compositions for preventing and treating neurodegenerative and blood coagulation disorders
Provided herein are methods and compositions for treating or preventing neurodegenerative disorders or blood coagulation disorders. Methods may comprise modulating the activity or level of a sirtuin, such as SIRT1 or Sir2. Exemplary methods comprise contacting a cell wi...
12/07/2006
20060229265Nicotinamide riboside and analogues thereof
Provided herein are sirtuin-modulating compounds and methods of use thereof. The sirtuin-modulating compounds may be used for increasing the lifespan of a cell, and treating and/or preventing a wide variety of diseases and disorders including, for example, diseases or d...
10/12/2006
 
Sign InRegister
Username  
Password   
forgot password?